作者: Bruce L. Levison , Stanley L. Hazen , Zeneng Wang
DOI:
关键词: Insulin resistance 、 Gastroenterology 、 Metabolic syndrome 、 Endocrinology 、 Disease 、 Diabetes mellitus 、 Medicine 、 Nonalcoholic steatohepatitis 、 Nonalcoholic fatty liver disease 、 Internal medicine
摘要: The present invention provides markers and methods for determining whether a subject, particularly human has or is at risk of developing, disease such as cardiovascular disease, diabetes mellitus, insulin resistance, metabolic syndrome, NAFLD (Nonalcoholic Fatty Liver Disease) NASH Steatohepatitis) (e.g., within the ensuing year, two years, and/or three years). application also relates to use monitoring status diseases in subject effects therapeutic agents on subjects with diseases.